Gubra A/S (CPH:GUBRA)
Denmark · Delayed Price · Currency is DKK 377.00
+5.20 (1.40%)
Aug 17, 2026, 4:59 PM CET
Gubra Financials Overview
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,637 | 2,637 | 265.74 | 205.01 | 199.38 | 255.33 |
Revenue Growth | -0.02% | 892.25% | 29.63% | 2.82% | -21.91% | 48.19% |
Gross Profit Gross Profit Growth | 2,557 | 2,557 | 164.5 | 114.94 | 97.75 | 165.88 |
Operating Income Operating Income Growth | 2,150 | 2,150 | -50.01 | -47.67 | -29.43 | 88.67 |
Net Income Net Income Growth | 1,691 | 1,691 | -36.5 | -44.52 | 4.31 | 67.94 |
Earnings Per Share EPS Growth | 102.70 | 102.70 | -2.24 | -2.93 | 0.37 | 517.50 |
EPS Growth | -5.12% | - | - | - | -99.93% | 430.37% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
CRO CRO Growth | 192.52 | 192.52 | 220.22 | 168.56 | 130.62 | 155.03 |
Biotech Biotech Growth | 2,444 | 2,444 | 45.52 | 36.45 | 68.76 | 100.3 |
Total Total Growth | 2,637 | 2,637 | 265.74 | 205.01 | 199.38 | 255.33 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,083 | 1,083 | 422.25 | 457.39 | 71.93 | 115.79 |
Total Debt Total Debt Growth | 107.44 | 107.44 | 96.45 | 71.44 | 69.4 | 52.44 |
Net Cash (Debt) Net Cash Growth | 975.52 | 975.52 | 325.8 | 385.95 | 2.52 | 63.34 |
Net Cash Growth | -62.90% | 199.43% | -15.59% | 15203.37% | -96.02% | 641.30% |
Net Cash Per Share Net Cash Per Share Growth | 59.26 | 59.26 | 19.64 | 25.44 | 0.21 | 482.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,712 | 1,712 | 5.02 | -49.42 | 24.34 | 88.51 |
Capital Expenditures CapEx Growth | -17.25 | -17.25 | -25.69 | -5.84 | -9.54 | -27.17 |
Free Cash Flow Free Cash Flow Growth | 1,695 | 1,695 | -20.67 | -55.26 | 14.8 | 61.34 |
Free Cash Flow Growth | -25.75% | - | - | - | -75.88% | 137.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 96.96% | 96.96% | 61.90% | 56.06% | 49.02% | 64.97% |
Operating Margin | 81.54% | 81.54% | -18.82% | -23.25% | -14.76% | 34.73% |
Pretax Margin | 81.71% | 81.71% | -15.96% | -20.93% | 3.14% | 34.11% |
Profit Margin | 64.11% | 64.11% | -13.73% | -21.72% | 2.16% | 26.61% |
FCF Margin | 64.29% | 64.29% | -7.78% | -26.96% | 7.42% | 24.02% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 516.490 | 500.000 |
Dividend Per Share Growth | 3.30% | 900.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.67 | 5.00 | - | - | - | - |
Forward PE | 33.66 | 15.75 | - | - | - | - |
P/FCF Ratio | 3.63 | 4.99 | - | - | - | - |
PS Ratio | 2.34 | 3.21 | 38.29 | 9.93 | - | - |